...
首页> 外文期刊>International ophthalmology clinics >Immunomodulatory Medications in Uveitis
【24h】

Immunomodulatory Medications in Uveitis

机译:葡萄膜炎的免疫调节药物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

It is difficult to obtain accurate numbers on the incidence and prevalence rates of uveitis because most studies are from referral clinics and tertiary care centers. Most studies report an incidence between 11 and 38 per 100,000 persons per year and prevalence between 30 and 200 patients per 100,000 inhabitants. There is significant variability in reporting the distribution of the various subtypes of uveitis depending on the clinical and geographical setting. On the average, anterior uveitis is most prevalent (-55%; range 30-60%), followed by posterior uveitis (-20%; 15-30%), panuveitis (-15%; 10-20%), and intermediate uveitis (-10%; 7-15%). There seems to be no overall gender predominance, and there is an increased incidence/prevalence in the 20- to 70-year-old age group.
机译:葡萄膜炎的发病率和患病率很难获得准确的数字,因为大多数研究来自转诊诊所和三级护理中心。大多数研究报告说,每年的发病率在每100,000人中11至38人之间,每100,000居民中30至200名患者之间的患病率。根据临床和地理环境,报告葡萄膜炎各种亚型的分布存在很大差异。平均而言,前葡萄膜炎最为普遍(-55%;范围为30-60%),其次为后葡萄膜炎(-20%; 15-30%),胰腺炎(-15%; 10-20%)和中级葡萄膜炎(-10%; 7-15%)。似乎没有整体的性别优势,并且20至70岁年龄段的发病率/患病率有所增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号